CD44 and cancer: Taken together, the results show that CD44 overexpression tends to have a predominantly negative impact on chemotherapy outcomes across various cancers, with a limited number of instances showing no effect or a potential positive effect, highlighting the complex and varied relationship between CD44 expression and treatment response in different cancer types.